Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
793,37 B | 23,56% | 6/6 | 34,75% | 19,09% | 42,11% | DOWN |
|
Johnson & Johnson NYSE:JNJ |
584,07 B | 5,27% | 5/5 | 6,91% | -32,83% | 1,04% | UP |
|
Merck NYSE:MRK |
291,99 B | 7,67% | 6/6 | -21,36% | -8,37% | 11,77% | UP |
|
Pfizer NYSE:PFE |
157,97 B | 7,82% | 4/6 | -5,31% | 19,76% | -2,77% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
121,95 B | 1,77% | 5/6 | -0,30% | -2,69% | 7,15% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
112,58 B | 13,44% | 6/6 | 6,43% | -2,76% | 25,91% | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
76,89 B | 9,26% | 5/6 | 5,41% | 4,58% | 16,78% | UP |
|
Zoetis NYSE:ZTS |
49,11 B | 9,80% | 6/6 | 7,18% | 47,84% | 24,65% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
25,79 B | 15,13% | 5/6 | 2,41% | -47,72% | 6,31% | UP |
|
Viatris NasdaqGS:VTRS |
14,92 B | -3,69% | 4/6 | 2,85% | -31,51% | 31,17% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
11,60 B | 0,00% | 2/4 | 0,00% | 0,00% | 26,96% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Cytokinetics NasdaqGS:CYTK |
7,76 B | -1,08% | 1/6 | 4,92% | -37,60% | 42,93% | UP |
|
Balchem NasdaqGS:BCPC |
5,46 B | 8,75% | 6/6 | 8,46% | 2,45% | 18,81% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
4,65 B | 63,45% | 3/5 | 33,54% | 93,46% | 45,99% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,53 B | 28,91% | 5/6 | 13,62% | 5,50% | 24,68% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
4,05 B | 10,36% | 5/6 | 118,76% | 23,10% | 57,44% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
3,85 B | 7,83% | 5/6 | 3,60% | -42,55% | 25,23% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,84 B | 2,48% | 3/6 | 8,61% | -26,46% | 31,71% | UP |
|
Endo OTCPK:NDOI |
1,80 B | 3,65% | 0/5 | 61,08% | 23,81% | -100,00% | DOWN |
